Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Boursi

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Hepatobiliary Surgery and Nutrition|November 11, 2021
Tailoring bacterial taxa for immune cell modulationOfer Margalit, Ben Boursi
Harefuah|November 4, 2004
[Small bowel malignancies: why are they so rare?]Ben Boursi, Nadir Arber
Current Pharmaceutical Design|August 21, 2007
Current and future clinical strategies in colon cancer prevention and the emerging role of chemopreventionBen Boursi, Nadir Arber
Cancer Journal (Sudbury, Mass.)|March 23, 2023
Fecal Microbiota Transplantation as a Cancer TherapeuticRonen Stoff, Yochai Wolf, Ben Boursi
Cancer Epidemiology|January 6, 2017
Proton pump inhibitors on pancreatic cancer risk and survivalMalcolm D Kearns, Ben Boursi, Yu-Xiao Yang
Cancer Epidemiology|May 28, 2016
Parkinson's disease and colorectal cancer risk-A nested case control studyBen Boursi, Ronac Mamtani, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Digoxin use and the risk for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
European Journal of Gastroenterology & Hepatology|September 30, 2014
Height as an independent anthropomorphic risk factor for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
Journal of the National Cancer Institute|April 10, 2015
Thyroid dysfunction, thyroid hormone replacement and colorectal cancer riskBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
Translational Oncology|March 15, 2025
Leveraging machine learning for integrative analysis of T-cell receptor repertoires in colorectal cancer: Insights into MAIT cell dynamics and risk assessmentRomi Goldner Kabeli, Ben Boursi, Alona Zilberberg, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Hepatobiliary Surgery and Nutrition|November 11, 2021
Tailoring bacterial taxa for immune cell modulationOfer Margalit, Ben Boursi
Harefuah|November 4, 2004
[Small bowel malignancies: why are they so rare?]Ben Boursi, Nadir Arber
Current Pharmaceutical Design|August 21, 2007
Current and future clinical strategies in colon cancer prevention and the emerging role of chemopreventionBen Boursi, Nadir Arber
Cancer Journal (Sudbury, Mass.)|March 23, 2023
Fecal Microbiota Transplantation as a Cancer TherapeuticRonen Stoff, Yochai Wolf, Ben Boursi
Cancer Epidemiology|January 6, 2017
Proton pump inhibitors on pancreatic cancer risk and survivalMalcolm D Kearns, Ben Boursi, Yu-Xiao Yang
Cancer Epidemiology|May 28, 2016
Parkinson's disease and colorectal cancer risk-A nested case control studyBen Boursi, Ronac Mamtani, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Digoxin use and the risk for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
European Journal of Gastroenterology & Hepatology|September 30, 2014
Height as an independent anthropomorphic risk factor for colorectal cancerBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
Journal of the National Cancer Institute|April 10, 2015
Thyroid dysfunction, thyroid hormone replacement and colorectal cancer riskBen Boursi, Kevin Haynes, Ronac Mamtani, et al.
Translational Oncology|March 15, 2025
Leveraging machine learning for integrative analysis of T-cell receptor repertoires in colorectal cancer: Insights into MAIT cell dynamics and risk assessmentRomi Goldner Kabeli, Ben Boursi, Alona Zilberberg, et al.
Pageof 11